Jefferson Capital Inc
JCAP
19.93
-0.02
-0.10%
Jefferson Capital Inc
US · JCAP
#3153 by market cap
Listed 2025
19.93
-0.02
-0.10%
Live - 5344 symbols - heartbeat 97s ago
· 2026-10-09 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 100.00% -0.27pp
- Institutions
- 144 +2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund56.98%
Mutual Fund26.96%
Hedge Fund9.80%
Individual/Insider9.77%
Private Company4.09%
Public Company1.09%
Government Pension Fund0.69%
Sovereign Wealth Fund0.23%
Insurance Company0.14%
Top holders as of 2026-03-31
J.C. Flowers & Co. LLC
56.98% · 32.72M sh
David Burton
5.91% · 3.39M sh
Wellington Management Group
4.04% · 2.32M sh
Adage Capital Management, L.P.
3.24% · 1.86M sh
William Blair Investment Management, LLC
3.15% · 1.81M sh
Principal Global Investors, LLC
2.98% · 1.71M sh
BlackRock
2.96% · 1.70M sh
Canaccede Financial Group Ltd.
2.55% · 1.47M sh
Punch & Associates Investment Management, Inc.
2.52% · 1.45M sh
Vanguard Capital Management, LLC
1.52% · 874.17K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
23 filings tracked · 3 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| J.C. Flowers & Co. LLC | -- | 56.98% |
| David Burton | Chief Executive Officer | 5.91% |
| Mark Zellmann | President of U.S. Business Lines | 1.10% |
| Matthew Pfohl | Chief Administrative Officer | 0.78% |
| Penelope Person | Chief Commercial Officer | 0.76% |
| Christo Realov | Chief Financial Officer | 0.19% |
| Christopher Giles | Director | 0.14% |
| Ronald Vaske | Director | 0.07% |
| Beth Leonard | Director | 0.03% |
| John Oros | Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-24 | Penelope Person | Chief Commercial Officer | Open Market Disposition | -246 | $22.04 |
| 2026-08-16 | Mark Zellmann | President of U.S. Business Lines | Other Disposition | -6,250 | -- |
| 2026-08-16 | Mark Zellmann | President of U.S. Business Lines | Open Market Disposition | -56,000 | $23.75 |
| 2026-03-17 | Mark Zellmann | President of U.S. Business Lines | Other Derivative Acquisition | +25,000 | -- |
| 2026-03-10 | John Oros | Director | Other Derivative Acquisition | +50,000 | -- |
| 2026-01-08 | J.C. Flowers & Co. LLC | -- | Private Disposition | -11,000,000 | $19.63 |
| 2026-01-08 | David Burton | Chief Executive Officer | Private Disposition | -385,000 | $20.50 |
| 2025-08-21 | J.C. Flowers & Co. LLC | -- | Other Disposition | -30,228,952 | -- |
| 2025-08-21 | J.C. Flowers & Co. LLC | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-06-26 | J.C. Flowers & Co. LLC | -- | Private Disposition | -6,021,280 | $15.00 |
| 2025-06-26 | David Burton | Chief Executive Officer | Private Disposition | -424,296 | $15.00 |
| 2025-06-25 | Beth Leonard | Director | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | J.C. Flowers & Co. LLC | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | David Burton | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Ronald Vaske | Director | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Mark Zellmann | President of U.S. Business Lines | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Christo Realov | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Matthew Pfohl | Chief Administrative Officer | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Penelope Person | Chief Commercial Officer | Initial Statement of Beneficial | 0 | -- |
| 2025-06-25 | Christopher Giles | Director | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-09 19:30:04 · For reference only, not investment advice and not tailored to your situation.
Jefferson Capital Inc discussion 0 comments